Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and stroke.
Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and stroke.
复制标题
DOI:
10.1002/ana.23876
复制
发表时间:
2013-06
影响因子:
11.2
通讯作者:
Auer, Dorothee P.
中科院分区:
文献类型:
--
作者:
Hosseini, Akram A.;Kandiyil, Neghal;MacSweeney, Shane T. S.;Altaf, Nishath;Auer, Dorothee P.
There is a recognized need to improve selection of patients with carotid artery stenosis for carotid endarterectomy (CEA). We assessed the value of magnetic resonance imaging (MRI)-defined carotid plaque hemorrhage (MRIPH) to predict recurrent ipsilateral cerebral ischemic events, and stroke in symptomatic carotid stenosis. One hundred seventy-nine symptomatic patients with ≥50% stenosis were prospectively recruited, underwent carotid MRI, and were clinically followed up until CEA, death, or ischemic event. MRIPH was diagnosed if the plaque signal intensity was >150% that of the adjacent muscle. Event-free survival analysis was done using Kaplan–Meier plots and Cox regression models controlling for known vascular risk factors. We also undertook a meta-analysis of reported data on MRIPH and recurrent events. One hundred fourteen patients (63.7%) showed MRIPH, suffering 92% (57 of 62) of all recurrent ipsilateral events and all but 1 (25 of 26) future strokes. Patients without MRIPH had an estimated annual absolute stroke risk of only 0.6%. Cox multivariate regression analysis proved MRIPH as a strong predictor of recurrent ischemic events (hazard ratio [HR] = 12.0, 95% confidence interval [CI] = 4.8–30.1, p < 0.001) and stroke alone (HR = 35.0, 95% CI = 4.7–261.6, p = 0.001). Meta-analysis of published data confirmed this association between MRIPH and recurrent cerebral ischemic events in symptomatic carotid artery stenosis (odds ratio = 12.2, 95% CI = 5.5–27.1, p < 0.00001). MRIPH independently and strongly predicts recurrent ipsilateral ischemic events, and stroke alone, in symptomatic ≥50% carotid artery stenosis. The very low stroke risk in patients without MRIPH puts into question current risk–benefit assessment for CEA in this subgroup. ANN NEUROL 2013;73:774–784
登录
查看更多内容
DOI:
10.1056/nejmoa0912321
发表时间:
2010-07-01
期刊:
The New England journal of medicine
影响因子:
--
作者:
Brott TG;Hobson RW 2nd;Howard G;Roubin GS;Clark WM;Brooks W;Mackey A;Hill MD;Leimgruber PP;Sheffet AJ;Howard VJ;Moore WS;Voeks JH;Hopkins LN;Cutlip DE;Cohen DJ;Popma JJ;Ferguson RD;Cohen SN;Blackshear JL;Silver FL;Mohr JP;Lal BK;Meschia JF;CREST Investigators
通讯作者:
CREST Investigators
DOI:
10.3174/ajnr.a2213
发表时间:
2010-09
期刊:
AJNR. American journal of neuroradiology
影响因子:
--
作者:
Demarco JK;Ota H;Underhill HR;Zhu DC;Reeves MJ;Potchen MJ;Majid A;Collar A;Talsma JA;Potru S;Oikawa M;Dong L;Zhao X;Yarnykh VL;Yuan C
通讯作者:
Yuan C
影响因子:
8.3
作者:
Altaf, Nishath;MacSweeney, Shane T.;Auer, Dorothee P.
通讯作者:
Auer, Dorothee P.
影响因子:
8.3
作者:
McCabe, DJH;Pereira, AC;Brown, MM
通讯作者:
Brown, MM
影响因子:
19.7
作者:
Altaf, Nishath;Goode, Stephen D.;Auer, Dorothee P.
通讯作者:
Auer, Dorothee P.